Related Experiment Video
Updated: Jun 14, 2025

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
Disease Severity and Activity in Bronchiectasis: A Paradigm Shift in Bronchiectasis Management
Yunjoo Im1, James D Chalmers2, Hayoung Choi3
1Division of Pulmonology and Allergy, Department of Internal Medicine, Kyung Hee University Medical Center, Seoul, Republic of Korea.
Identifying high-risk bronchiectasis patients early is crucial. Focusing on disease activity, not just severity, helps predict progression and improve patient outcomes.
Area of Science:
- Pulmonology
- Respiratory Medicine
Background:
- Bronchiectasis prevalence and burden are increasing.
- Current methods using disease severity indices (e.g., BSI, FACED) identify advanced disease, not early risk.
- Early intervention is key to preventing progression and improving outcomes.
Purpose of the Study:
- To propose a paradigm shift in bronchiectasis management.
- To focus on disease activity for early risk identification.
- To prevent disease progression and improve long-term outcomes.
Main Methods:
- Review of current bronchiectasis management strategies.
- Discussion of the limitations of disease severity assessment.
- Exploration of disease activity as a predictive measure.
Main Results:
- Disease severity indices indicate advanced lung destruction.
- Disease activity reflects underlying pathophysiological processes.
- Clinical presentations and biomarkers can measure disease activity.
Conclusions:
- Shifting focus from disease severity to disease activity is necessary for early risk identification in bronchiectasis.
- Assessing disease activity allows for earlier intervention.
- This approach aims to prevent disease progression and enhance patient management.
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Cystic Fibrosis: Management
Sinus disease and chronic...
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-I: Introduction
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

